Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia

Psychological Medicine

Volumn 41, Issue 6, 2011, Pages 1253-1261

  Eack, S M ^a,b   Pogue Geile, M F ^c   Greenwald, D P ^b   Hogarty, S S ^b   Keshavan, M S ^b,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cognitive rehabilitation; cognitive remediation; psychosocial treatment; social cognition

Indexed keywords

ADULT; ARTICLE; COGNITIVE DEFECT; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMOTIONAL INTELLIGENCE; FEMALE; HUMAN; MALE; METHODOLOGY; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOMETRY; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SCHIZOPHRENIA; STATISTICS;

ADULT; COGNITION DISORDERS; COGNITIVE THERAPY; EMOTIONAL INTELLIGENCE; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 79956028854     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291710001765     Document Type: Article

References (44)

1. Baron RM, Kenny DA (1986). The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology 51, 1173-1182.
2. Brekke JS, Hoe M, Green MF (2009). Neurocognitive change, functional change and service intensity during community-based psychosocial rehabilitation for schizophrenia. Psychological Medicine 39, 1637-1647.
3. Brekke JS, Hoe M, Long J, Green MF (2007). How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia. Schizophrenia Bulletin 33, 1247-1256. (Pubitemid 47347914)
4. Buchanan RW, Heinrichs DW (1989). The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research 27, 335-350. (Pubitemid 19096791)
5. Campbell DT, Stanley JC (1963). Experimental and Quasi-Experimental Designs for Research. Houghton Mifflin : Boston, MA.
6. Couture SM, Penn DL, Roberts DL (2006). The functional significance of social cognition in schizophrenia: a review. Schizophrenia Bulletin 32 (Suppl. 1), S44-S63.
7. Delis DC, Kramer JH, Kaplan E, Ober BA (1987). California Verbal Learning Test Manual. Psychological Corp.: San Antonio, TX.
8. Dempster AP, Laird NM, Rubin DB (1977). Maximum likelihood from incomplete data using the EM algorithm. Journal of the Royal Statistical Society. Series B (Methodological) 39, 1-38.
9. Department of Health and Human Services (1986). Disability Evaluation Under Social Security. Department of Health and Human Services: Washington, DC.
10. Eack SM, Greeno CG, Pogue-Geile MF, Newhill CE, Hogarty GE, Keshavan MS (2010). Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test. Schizophrenia Bulletin 36, 370-380.
11. Eack SM, Greenwald DP, Hogarty SS, Cooley SJ, DiBarry AL, Montrose DM, Keshavan MS (2009). Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatric Services 60, 1468-1476.
12. Eack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MS (2007). Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects. Schizophrenia Research 89, 308-311. (Pubitemid 44881288)
13. Eack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MS (in press). Effects of cognitive enhancement therapy on employment outcomes in early schizophrenia: results from a two-year randomized trial. Research on Social Work Practice.
14. Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976). The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766-771.
15. First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. Biometrics Research, New York State Psychiatric Institute: New York.
16. Green MF, Kern RS, Braff DL, Mintz J (2000). Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the right stuff? Schizophrenia Bulletin 26, 119-136. (Pubitemid 30317696)
17. Green MF, Nuechterlein KH (1999). Should schizophrenia be treated as a neurocognitive disorder? Schizophrenia Bulletin 25, 309-319. (Pubitemid 29272507)
18. Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RS, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry 56, 301-307. (Pubitemid 39164514)
19. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G (1993). Wisconsin Card Sorting Test Manual: Revised and Expanded. Psychological Assessment Resources Inc. : Odessa, FL.
20. Heinrichs RW, Zakzanis KK (1998). Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12, 426-445. (Pubitemid 28323862)
21. Hogarty GE (2002). Personal Therapy for Schizophrenia and Related Disorders: A Guide to Individualized Treatment. Guilford: New York.
22. Hogarty GE, Flesher S (1992). Cognitive remediation in schizophrenia: proceed with caution! Schizophrenia Bulletin 18, 51-57.
23. Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R (2004). Cognitive enhancement therapy for schizophrenia. Effects of a 2-year randomized trial on cognition and behavior. Archives of General Psychiatry 61, 866-876. (Pubitemid 39181076)
24. Hogarty GE, Goldberg SC, Schooler NR, the Collaborative Study Group (1974). Drug and sociotherapy in the aftercare of schizophrenic patients: III. Adjustment of nonrelapsed patients. Archives of General Psychiatry 31, 609-618.
25. Hogarty GE, Greenwald DP (2006). Cognitive enhancement therapy (http://www.cognitiveenhancementtherapy. com). Accessed 1 September 2010.
26. Hogarty GE, Greenwald DP, Eack SM (2006). Durability and mechanism of effects of cognitive enhancement therapy. Psychiatric Services 57, 1751-1757. (Pubitemid 46051330)
27. Keefe RSE, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA; CATIE Investigators; Neurocognitive Working Group (2007). Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Archives of General Psychiatry 64, 633-647. (Pubitemid 46878665)
28. Kraemer HC, Wilson G, Fairburn CG, Agras W (2002). Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 59, 877-884.
29. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V (2002). A comparison of methods to test mediation and other intervening variable effects. Psychological Methods 7, 83-104.
30. Mayer JD, Salovey P, Caruso DR, Sitarenios G (2003). Measuring emotional intelligence with the MSCEIT V2.0. Emotion 3, 97-105. (Pubitemid 37322448)
31. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT (2007). A meta-analysis of cognitive remediation in schizophrenia. American Journal of Psychiatry 164, 1791-1802. (Pubitemid 351739231)
32. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese 3rd FJ, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR (2008). The MATRICS Consensus Cognitive Battery, Part 1: test selection, reliability, and validity. American Journal of Psychiatry 165, 203-213. (Pubitemid 351704520)
33. Penn DL, Corrigan PW, Bentall RP, Racenstein J, Newman L (1997). Social cognition in schizophrenia. Psychological Bulletin 121, 114-132. (Pubitemid 127705287)
34. Reeder C, Newton E, Frangou S, Wykes T (2004). Which executive skills should we target to affect social functioning and symptom change? A study of a cognitive remediation therapy program. Schizophrenia Bulletin 30, 87-100. (Pubitemid 38568787)
35. Reeder C, Smedley N, Butt K, Bogner D, Wykes T (2006). Cognitive predictors of social functioning improvements following cognitive remediation for schizophrenia. Schizophrenia Bulletin 32 (Suppl. 1), S123-S131.
36. Reitan RM, Waltson D (1985). The Halstead-Reitan Neuropsychological Test Battery. Neuropsychology Press: Tucson, AZ.
37. Salovey P, Mayer JD (1990). Emotional intelligence. Imagination, Cognition, and Personality 9, 185-221.
38. Schooler N, Weissman M, Hogarty G (1979). Social adjustment scale for schizophrenics. In Resource Material for Community Mental Health Program Evaluators (ed. W. A. Hargreaves, C. C. Attkisson and J. Sorenson), pp. 290-303. DHHS publication no. (ADM) 79328. United States Department of Health, Education, and Welfare; Rockville, MD.
39. Sergi MJ, Green MF, Widmark C, Reist C, Erhart S, Braff DL, Kee KS, Marder SR, Mintz J (2007). Cognition and neurocognition: effects of Risperidone, Olanzapine, and Haloperidol. American Journal of Psychiatry 164, 1585-1592. (Pubitemid 350069739)
40. Sergi MJ, Rassovsky Y, Nuechterlein KH, Green MF (2006). Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. American Journal of Psychiatry 163, 448-454. (Pubitemid 44469387)
41. Singer JD, Willet JB (2003). Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. Oxford University Press: New York.
42. Wechsler D (1981). Wechsler Adult Intelligence Scale-Revised. Psychological Corp.: New York.
43. Wechsler D (1987). Manual for the Wechsler Memory Scale-Revised. Psychological Corp.: San Antonio, TX.
44. Wykes T, Newton E, Landau S, Rice C, Thompson N, Frangou S (2007). Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophrenia Research 94, 221-230. (Pubitemid 47031576)